Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2003-4-14
pubmed:abstractText
The t(2;5) translocation results in a 80-kDa oncogenic fusion protein consisting of NPM and the kinase domain of the tyrosine kinase ALK and is present in over half the cases of anaplastic large cell lymphoma (ALCL). NPM/ALK exerts its transforming potential via activation of multiple signaling pathways promoting growth factor independence and protection from apoptosis. Jak/Stat signaling is aberrantly activated in several human hematopoietic malignancies. We investigated the role of Jak2 in the context of NPM/ALK-mediated oncogenesis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Caseins, http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/JAK2 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Jak2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Janus Kinase 2, http://linkedlifedata.com/resource/pubmed/chemical/Luciferases, http://linkedlifedata.com/resource/pubmed/chemical/Milk Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Phosphotyrosine, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins, http://linkedlifedata.com/resource/pubmed/chemical/STAT5 Transcription Factor, http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators, http://linkedlifedata.com/resource/pubmed/chemical/Tyrphostins, http://linkedlifedata.com/resource/pubmed/chemical/alpha-cyano-(3,4-dihydroxy)-N-benzyl..., http://linkedlifedata.com/resource/pubmed/chemical/p80(NPM-ALK) protein
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0301-472X
pubmed:author
pubmed:issnType
Print
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-15
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12691918-Animals, pubmed-meshheading:12691918-Apoptosis, pubmed-meshheading:12691918-B-Lymphocytes, pubmed-meshheading:12691918-Caseins, pubmed-meshheading:12691918-Cell Division, pubmed-meshheading:12691918-Cell Line, Transformed, pubmed-meshheading:12691918-Cell Transformation, Neoplastic, pubmed-meshheading:12691918-DNA-Binding Proteins, pubmed-meshheading:12691918-Enzyme Activation, pubmed-meshheading:12691918-Enzyme Inhibitors, pubmed-meshheading:12691918-Gene Expression, pubmed-meshheading:12691918-Hematopoietic Stem Cells, pubmed-meshheading:12691918-Immunosorbent Techniques, pubmed-meshheading:12691918-Janus Kinase 2, pubmed-meshheading:12691918-Luciferases, pubmed-meshheading:12691918-Mice, pubmed-meshheading:12691918-Milk Proteins, pubmed-meshheading:12691918-Phosphorylation, pubmed-meshheading:12691918-Phosphotyrosine, pubmed-meshheading:12691918-Promoter Regions, Genetic, pubmed-meshheading:12691918-Protein-Tyrosine Kinases, pubmed-meshheading:12691918-Proto-Oncogene Proteins, pubmed-meshheading:12691918-STAT5 Transcription Factor, pubmed-meshheading:12691918-Trans-Activators, pubmed-meshheading:12691918-Transcription, Genetic, pubmed-meshheading:12691918-Transfection, pubmed-meshheading:12691918-Tyrphostins
pubmed:year
2003
pubmed:articleTitle
Constitutive activation of Jak2 contributes to proliferation and resistance to apoptosis in NPM/ALK-transformed cells.
pubmed:affiliation
The National Cancer Institute, Oncogenic Fusion Proteins Unit, Department of Experimental Oncology, Milan, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't